According to our latest research, the global COVID-19 vaccine development tools market size reached USD 4.8 billion in 2024, reflecting a robust industry driven by the urgent need for advanced vaccine research and development. The market is projected to grow at a CAGR of 7.2% from 2025 to 2033, reaching a forecasted value of USD 8.97 billion by 2033. This growth is fueled by ongoing investments in biotechnology, the evolution of viral variants, and the continuous demand for improved vaccine efficacy and safety. As per our latest research, the market's expansion is also supported by regulatory support and the integration of digital technologies into vaccine development processes.
growthmarketreports.com/repo...